Balance Sheet Insmed Incorporated

Equities

INSM

US4576693075

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 17/07/2025 am IST			5-day change	1st Jan Change
104.59 ^USD	+1.67%		+8.79%	+51.49%

16/07	Insmed Insider Sold Shares Worth $699,220, According to a Recent SEC Filing	MT
10/07	Insmed Insider Sold Shares Worth $5,537,460, According to a Recent SEC Filing	MT

05b9672cb43a9c7bb14fc0b4d198600._kyy2oOmj2qF73hWpHKVhvQhPFArlgblSvz0hKz2Drc.hDrlgtDB2ivHvD0sxSPhzbdpY2dj4jaVLrqRvdajePq4Fcq42eH6AtPaSA

Published financial data: INSMED INCORPORATED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	16Cr	19Cr	25Cr	31Cr	36Cr
Total Revenues	16Cr	19Cr	25Cr	31Cr	36Cr
Cost of Goods Sold, Total	13Cr	4.42Cr	5.51Cr	6.56Cr	8.57Cr
Gross Profit	3.39Cr	14Cr	19Cr	24Cr	28Cr
Selling General & Admin Expenses, Total	20Cr	23Cr	27Cr	34Cr	46Cr
R&D Expenses	9.05Cr	27Cr	40Cr	57Cr	60Cr
Amortization of Goodwill and Intangible Assets - (IS)	50.03L	50.52L	50.53L	50.52L	50.52L
Other Operating Expenses, Total	30Cr	51Cr	67Cr	92Cr	106.45Cr
Operating Income	-27Cr	-37Cr	-48Cr	-68Cr	-79Cr
Interest Expense, Total	-2.96Cr	-4.05Cr	-2.8Cr	-8.14Cr	-8.51Cr
Interest And Investment Income	17.03L	2L	1.11Cr	4.21Cr	5.33Cr
Net Interest Expenses	-2.79Cr	-4.03Cr	-1.69Cr	-3.92Cr	-3.18Cr
Other Non Operating Income (Expenses)	4L	-33.3L	-59.39L	18.56L	29T
EBT, Excl. Unusual Items	-29Cr	-41Cr	-50Cr	-72Cr	-82Cr
Merger & Related Restructuring Charges	-	-6L	-	-	-
Other Unusual Items	-	-2.5Cr	2.08Cr	-2.87Cr	-9.17Cr
EBT, Incl. Unusual Items	-29Cr	-44Cr	-48Cr	-75Cr	-91Cr
Income Tax Expense	14.02L	-17.58L	13.83L	25.55L	37.07L
Earnings From Continuing Operations	-29Cr	-43Cr	-48Cr	-75Cr	-91Cr
Net Income to Company	-29Cr	-43Cr	-48Cr	-75Cr	-91Cr
Net Income - (IS)	-29Cr	-43Cr	-48Cr	-75Cr	-91Cr
Net Income to Common Incl Extra Items	-29Cr	-43Cr	-48Cr	-75Cr	-91Cr
Net Income to Common Excl. Extra Items	-29Cr	-43Cr	-48Cr	-75Cr	-91Cr
Per Share Items
Net EPS - Basic	-3.01	-3.88	-3.91	-5.34	-5.57
Basic EPS - Continuing Operations	-3.01	-3.88	-3.91	-5.34	-5.57
Basic Weighted Average Shares Outstanding	9.76Cr	11Cr	12Cr	14Cr	16Cr
Net EPS - Diluted	-3.01	-3.88	-3.91	-5.34	-5.57
Diluted EPS - Continuing Operations	-3.01	-3.88	-3.91	-5.34	-5.57
Diluted Weighted Average Shares Outstanding	9.76Cr	11Cr	12Cr	14Cr	16Cr
Normalized Basic EPS	-1.87	-2.29	-2.54	-3.2	-3.12
Normalized Diluted EPS	-1.87	-2.29	-2.54	-3.2	-3.12
Supplemental Items
EBITDA	-25Cr	-36Cr	-47Cr	-67Cr	-78Cr
EBITA	-27Cr	-37Cr	-48Cr	-68Cr	-79Cr
EBIT	-27Cr	-37Cr	-48Cr	-68Cr	-79Cr
EBITDAR	-24Cr	-34Cr	-45Cr	-65Cr	-74Cr
Effective Tax Rate - (Ratio)	-0.48	0.4	-0.29	-0.34	-0.41
Current Domestic Taxes	3L	1L	3L	4L	4L
Current Foreign Taxes	11.34L	15.85L	13.45L	22.31L	33.8L
Total Current Taxes	14.02L	16.89L	16.14L	26.09L	37.36L
Deferred Domestic Taxes	-	-34.47L	-2L	-54T	-29T
Total Deferred Taxes	-	-34.47L	-2L	-54T	-29T
Normalized Net Income	-18Cr	-26Cr	-31Cr	-45Cr	-51Cr
Interest on Long-Term Debt	2.96Cr	4.05Cr	2.64Cr	8.17Cr	8.49Cr
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	19Cr	28Cr	40Cr	58Cr	60Cr
Net Rental Expense, Total	1.86Cr	1.92Cr	2.42Cr	2.45Cr	3.62Cr
Imputed Operating Lease Interest Expense	1.1Cr	1.22Cr	55.82L	1.19Cr	1.85Cr
Imputed Operating Lease Depreciation	76.34L	69.64L	1.86Cr	1.26Cr	1.77Cr
Stock-Based Comp., R&D Exp. (Total)	1.18Cr	1.78Cr	2.64Cr	3.59Cr	4.77Cr
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	2.44Cr	2.82Cr	3.13Cr	3.89Cr	4.92Cr
Stock-Based Comp., Other (Total)	12L	13L	13L	-	-
Total Stock-Based Compensation	3.74Cr	4.73Cr	5.9Cr	7.48Cr	9.68Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	53Cr	72Cr	107.4Cr	48Cr	56Cr
Short Term Investments	-	-	7.42Cr	30Cr	88Cr
Total Cash And Short Term Investments	53Cr	72Cr	114.83Cr	78Cr	143.38Cr
Accounts Receivable, Total	1.66Cr	2.44Cr	2.97Cr	4.12Cr	5.2Cr
Total Receivables	1.66Cr	2.44Cr	2.97Cr	4.12Cr	5.2Cr
Inventory	4.96Cr	6.7Cr	6.99Cr	8.32Cr	9.86Cr
Prepaid Expenses	2.4Cr	2.89Cr	2.55Cr	2.42Cr	3.72Cr
Total Current Assets	62Cr	84Cr	127.34Cr	93Cr	162.17Cr
Gross Property Plant And Equipment	13Cr	13Cr	14Cr	15Cr	17Cr
Accumulated Depreciation	-2.84Cr	-3.71Cr	-3.94Cr	-4.46Cr	-5.03Cr
Net Property Plant And Equipment	9.72Cr	9.55Cr	10Cr	10Cr	12Cr
Long-term Investments	-	5Cr	-	-	-
Goodwill	-	14Cr	14Cr	14Cr	14Cr
Other Intangibles, Total	19.72L	3.14Cr	3.12Cr	3.1Cr	3.08Cr
Deferred Charges Long-Term	4.73Cr	4.24Cr	3.76Cr	3.27Cr	2.79Cr
Other Long-Term Assets, Total	2.68Cr	5.1Cr	7.61Cr	9.66Cr	9.32Cr
Total Assets	80Cr	124.35Cr	165.64Cr	132.98Cr	202.52Cr
Liabilities
Accounts Payable, Total	4.29Cr	3.58Cr	5.05Cr	6.54Cr	7.3Cr
Accrued Expenses, Total	6.3Cr	8.38Cr	11Cr	13Cr	18Cr
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	1.26Cr	1.01Cr	81.26L	1.06Cr	1.23Cr
Other Current Liabilities	4L	54.34L	2.36Cr	2.14Cr	3.07Cr
Total Current Liabilities	12Cr	14Cr	19Cr	23Cr	30Cr
Long-Term Debt	36Cr	57Cr	127.33Cr	131.03Cr	126.44Cr
Long-Term Leases	3.6Cr	3.55Cr	4.45Cr	3.8Cr	3.32Cr
Other Non Current Liabilities	91.78L	9.57Cr	6.05Cr	8.77Cr	14Cr
Total Liabilities	52Cr	83Cr	156.85Cr	166.18Cr	173.99Cr
Common Stock, Total	10.28L	11.87L	13.57L	14.8L	17.94L
Additional Paid In Capital	210.53Cr	267.36Cr	278.24Cr	311.35Cr	464.58Cr
Retained Earnings	-183.06Cr	-226.52Cr	-269.66Cr	-344.61Cr	-435.99Cr
Comprehensive Income and Other	2L	10L	8L	-7L	-22.89L
Total Common Equity	28Cr	41Cr	8.8Cr	-33Cr	29Cr
Total Equity	28Cr	41Cr	8.8Cr	-33Cr	29Cr
Total Liabilities And Equity	80Cr	124.35Cr	165.64Cr	132.98Cr	202.52Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10Cr	12Cr	14Cr	15Cr	18Cr
ECS Total Common Shares Outstanding	10Cr	12Cr	14Cr	15Cr	18Cr
Book Value / Share	2.68	3.46	0.65	-2.24	1.59
Tangible Book Value	27Cr	24Cr	-7.93Cr	-50Cr	12Cr
Tangible Book Value Per Share	2.67	2.05	-0.58	-3.37	0.66
Total Debt	40Cr	61Cr	132.59Cr	135.9Cr	130.99Cr
Net Debt	-13Cr	-15Cr	18Cr	58Cr	-12Cr
Debt Equivalent Oper. Leases	15Cr	15Cr	19Cr	20Cr	29Cr
Account Code - Inventory Valuation	3	3	3	5	5
Inventories - Raw Materials, Total	2.16Cr	2.95Cr	2.72Cr	2.46Cr	1.97Cr
Inventories - Work In Process, Total	1.88Cr	1.85Cr	2.25Cr	3.35Cr	3.99Cr
Inventories - Finished Goods, Total	92.37L	1.89Cr	2.02Cr	2.52Cr	3.9Cr
Machinery, Total	2.52Cr	2.62Cr	2.94Cr	3.65Cr	4.12Cr
Full Time Employees	521	613	736	912	1.27T

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-29Cr	-43Cr	-48Cr	-75Cr	-91Cr
Depreciation & Amortization - CF	1.02Cr	1.02Cr	72.38L	82.39L	86.73L
Amortization of Goodwill and Intangible Assets - (CF)	2L	2L	2L	2L	2L
Depreciation & Amortization, Total	1.04Cr	1.04Cr	74.4L	84.41L	88.75L
Amortization of Deferred Charges, Total - (CF)	2.52Cr	3.59Cr	88.42L	1.22Cr	1.17Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	15.26L	-97.03L	-1.89Cr
Stock-Based Compensation (CF)	3.62Cr	4.6Cr	5.77Cr	7.48Cr	9.68Cr
Other Operating Activities, Total	59.32L	3.76Cr	-10L	17Cr	13Cr
Change In Accounts Receivable	26.7L	-81.18L	-64.23L	-1.2Cr	-1.29Cr
Change In Inventories	-2.12Cr	-1.75Cr	-17.14L	-1.36Cr	-1.7Cr
Change In Accounts Payable	2.98Cr	-75.75L	5Cr	1.52Cr	4.46Cr
Change in Other Net Operating Assets	-1.43Cr	-2.54Cr	-3.53Cr	-2.88Cr	-1.78Cr
Cash from Operations	-22Cr	-36Cr	-40Cr	-54Cr	-68Cr
Capital Expenditure	-62.4L	-72.89L	-98.78L	-1.33Cr	-2.19Cr
Cash Acquisitions	-	-67.04L	-	-	-
Sale (Purchase) of Intangible assets	-6L	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-5.03Cr	-2.47Cr	-21Cr	-56Cr
Other Investing Activities, Total	-	-	-	34.17L	-
Cash from Investing	-68.22L	-6.43Cr	-3.46Cr	-22Cr	-58Cr
Long-Term Debt Issued, Total	-	58Cr	50Cr	-	15Cr
Total Debt Issued	-	58Cr	50Cr	-	15Cr
Long-Term Debt Repaid, Total	-9L	-22Cr	-	-12.17L	-26.1L
Total Debt Repaid	-9L	-22Cr	-	-12.17L	-26.1L
Issuance of Common Stock	27Cr	29Cr	31Cr	17Cr	119.74Cr
Other Financing Activities, Total	-	-2.94Cr	-1.84Cr	-12.18L	-37.37L
Cash from Financing	27Cr	61Cr	79Cr	17Cr	134.1Cr
Foreign Exchange Rate Adjustments	5L	-9L	-10L	-2L	-13.07L
Net Change in Cash	4.53Cr	18Cr	36Cr	-59Cr	7.27Cr
Supplemental Items
Cash Interest Paid	91.86L	1.09Cr	1.02Cr	3.58Cr	4.06Cr
Cash Income Tax Paid (Refund)	8L	15.58L	17.17L	19.55L	24.99L
Levered Free Cash Flow	-11Cr	-18Cr	-20Cr	-38Cr	-42Cr
Unlevered Free Cash Flow	-11Cr	-19Cr	-19Cr	-34Cr	-37Cr
Change In Net Working Capital	-1.09Cr	1.13Cr	-5.22Cr	-93.57L	-3.1Cr
Net Debt Issued / Repaid	-9L	35Cr	50Cr	-12.17L	15Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-21.55	-22.5	-20.61	-28.5	-29.31
Return on Total Capital	-24.75	-26.94	-24.53	-34.87	-37.49
Return On Equity %	-109.42	-126.66	-193.22	614.47	3.93T
Return on Common Equity	-109.42	-126.66	-193.22	614.47	3.93T
Margin Analysis
Gross Profit Margin %	20.6	76.57	77.53	78.52	76.43
SG&A Margin	123.84	123.99	108.32	112.87	126.78
EBITDA Margin %	-155.01	-189.3	-191.84	-220.34	-213.82
EBITA Margin %	-161.23	-194.71	-194.79	-223.04	-216.21
EBIT Margin %	-161.32	-194.82	-194.87	-223.1	-216.26
Income From Continuing Operations Margin %	-178.87	-230.63	-196.26	-245.59	-251.24
Net Income Margin %	-178.87	-230.63	-196.26	-245.59	-251.24
Net Avail. For Common Margin %	-178.87	-230.63	-196.26	-245.59	-251.24
Normalized Net Income Margin	-111.26	-136.23	-127.61	-147.1	-140.63
Levered Free Cash Flow Margin	-65.2	-95.4	-80.97	-126.14	-115.01
Unlevered Free Cash Flow Margin	-66.36	-98.44	-75.48	-111.87	-102.27
Asset Turnover
Asset Turnover	0.21	0.18	0.17	0.2	0.22
Fixed Assets Turnover	1.56	1.96	2.48	2.96	3.31
Receivables Turnover (Average Receivables)	9.19	9.21	9.08	8.61	7.8
Inventory Turnover (Average Inventory)	3.35	0.76	0.81	0.86	0.94
Short Term Liquidity
Current Ratio	5.24	6.19	6.69	4.12	5.45
Quick Ratio	4.62	5.48	6.19	3.64	4.99
Operating Cash Flow to Current Liabilities	-1.85	-2.69	-2.1	-2.38	-2.3
Days Sales Outstanding (Average Receivables)	39.84	39.62	40.21	42.4	46.89
Days Outstanding Inventory (Average Inventory)	109.2	481.96	453.32	426.3	388.07
Average Days Payable Outstanding	67.54	233.09	271.19	267.98	250.63
Cash Conversion Cycle (Average Days)	81.5	288.49	222.34	200.71	184.33
Long Term Solvency
Total Debt/Equity	146.74	149.16	1.51T	-409.44	459.02
Total Debt / Total Capital	59.47	59.87	93.78	132.32	82.11
LT Debt/Equity	142.19	146.69	1.5T	-406.23	454.7
Long-Term Debt / Total Capital	57.63	58.87	93.2	131.28	81.34
Total Liabilities / Total Assets	65.35	66.99	94.69	124.96	85.91
EBIT / Interest Expense	-8.97	-9.07	-17.09	-8.37	-9.24
EBITDA / Interest Expense	-7.99	-8.34	-15.96	-7.96	-8.71
(EBITDA - Capex) / Interest Expense	-8.2	-8.52	-16.32	-8.13	-8.97
Total Debt / EBITDA	-1.71	-1.81	-2.97	-2.1	-1.77
Net Debt / EBITDA	0.54	0.46	-0.4	-0.89	0.17
Total Debt / (EBITDA - Capex)	-1.67	-1.78	-2.91	-2.06	-1.72
Net Debt / (EBITDA - Capex)	0.53	0.45	-0.39	-0.87	0.16
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	20.48	14.63	30.19	24.39	19.17
Gross Profit, 1 Yr. Growth %	-39.61	15.87	31.82	25.97	16
EBITDA, 1 Yr. Growth %	11.02	39.98	31.94	42.87	15.64
EBITA, 1 Yr. Growth %	12.75	38.43	30.24	42.44	15.52
EBIT, 1 Yr. Growth %	12.75	38.43	30.22	42.42	15.51
Earnings From Cont. Operations, 1 Yr. Growth %	15.63	47.8	10.79	55.66	21.91
Net Income, 1 Yr. Growth %	15.63	47.8	10.79	55.66	21.91
Normalized Net Income, 1 Yr. Growth %	15.43	40.35	21.95	43.39	13.93
Diluted EPS Before Extra, 1 Yr. Growth %	0.1	28.77	0.87	36.44	4.31
Accounts Receivable, 1 Yr. Growth %	-13.88	47.03	22.02	38.62	26.28
Inventory, 1 Yr. Growth %	75.16	35.12	4.35	19.06	18.41
Net Property, Plant and Equip., 1 Yr. Growth %	-14.04	-1.77	6.87	2.26	10.73
Total Assets, 1 Yr. Growth %	7.26	56.19	33.21	-19.72	52.29
Tangible Book Value, 1 Yr. Growth %	5.3	-11.29	-132.65	529.04	-123.75
Common Equity, 1 Yr. Growth %	5.43	48.78	-78.57	-477.4	-185.98
Cash From Operations, 1 Yr. Growth %	-12.49	65.63	10.22	33.91	27.53
Capital Expenditures, 1 Yr. Growth %	-85.24	16.81	35.52	34.52	64.98
Levered Free Cash Flow, 1 Yr. Growth %	-46.06	67.7	10.51	92.51	8.65
Unlevered Free Cash Flow, 1 Yr. Growth %	-45.67	70.05	-0.18	83.09	8.94
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	308.87	17.52	22.16	27.26	21.75
Gross Profit, 2 Yr. CAGR %	113.74	13.38	23.59	28.86	20.88
EBITDA, 2 Yr. CAGR %	-8.21	26	37.21	38.24	29.21
EBITA, 2 Yr. CAGR %	-6.94	26.24	35.52	37.11	28.93
EBIT, 2 Yr. CAGR %	-7.1	24.93	34.26	36.18	28.26
Earnings From Cont. Operations, 2 Yr. CAGR %	-4.77	30.73	27.96	31.32	37.75
Net Income, 2 Yr. CAGR %	-4.77	30.73	27.96	31.32	37.75
Normalized Net Income, 2 Yr. CAGR %	-4.64	27.28	30.83	32.24	27.81
Diluted EPS Before Extra, 2 Yr. CAGR %	-15.5	13.54	13.97	17.32	19.3
Accounts Receivable, 2 Yr. CAGR %	73.29	12.52	33.94	30.06	32.31
Inventory, 2 Yr. CAGR %	165.56	53.84	18.74	11.46	18.74
Net Property, Plant and Equip., 2 Yr. CAGR %	107.26	-8.11	2.46	4.54	6.41
Total Assets, 2 Yr. CAGR %	14.76	29.43	44.24	3.41	10.57
Tangible Book Value, 2 Yr. CAGR %	15.15	-3.35	-46.18	43.3	22.22
Common Equity, 2 Yr. CAGR %	15.09	25.24	-43.54	-10.08	80.13
Cash From Operations, 2 Yr. CAGR %	-7.79	20.39	35.11	21.49	30.68
Capital Expenditures, 2 Yr. CAGR %	-30.96	-58.47	25.82	35.02	48.98
Levered Free Cash Flow, 2 Yr. CAGR %	-16.59	-4.89	36.16	45.81	44.63
Unlevered Free Cash Flow, 2 Yr. CAGR %	-16.22	-3.88	30.31	35.19	41.23
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	167.6	21.6	22.9	24.5
Gross Profit, 3 Yr. CAGR %	-	169.02	19.22	24.38	24.42
EBITDA, 3 Yr. CAGR %	11.07	5.65	27.95	39.07	30.26
EBITA, 3 Yr. CAGR %	11.95	6.23	27.56	37.79	29.5
EBIT, 3 Yr. CAGR %	11.97	6.11	26.67	36.93	28.91
Earnings From Cont. Operations, 3 Yr. CAGR %	15.14	10.26	23.71	36.6	28.1
Net Income, 3 Yr. CAGR %	15.14	10.26	23.71	36.6	28.1
Normalized Net Income, 3 Yr. CAGR %	14.91	8.47	25.48	34.89	25.83
Diluted EPS Before Extra, 3 Yr. CAGR %	1.36	-2.76	9.15	21.02	12.81
Accounts Receivable, 3 Yr. CAGR %	-	64.06	15.6	35.48	28.78
Inventory, 3 Yr. CAGR %	-	112.01	35.17	18.85	13.73
Net Property, Plant and Equip., 3 Yr. CAGR %	98.5	61.59	-3.36	2.39	6.56
Total Assets, 3 Yr. CAGR %	19.89	27.18	30.68	18.65	17.65
Tangible Book Value, 3 Yr. CAGR %	-8.8	5.56	-32.69	22.13	-21.29
Common Equity, 3 Yr. CAGR %	-8.58	25.38	-30.47	6.36	-11.41
Cash From Operations, 3 Yr. CAGR %	11.18	12.09	16.9	34.71	23.47
Capital Expenditures, 3 Yr. CAGR %	27.64	-17.73	-38.4	28.65	44.35
Levered Free Cash Flow, 3 Yr. CAGR %	6.48	5.28	-0.01	53.16	32.19
Unlevered Free Cash Flow, 3 Yr. CAGR %	8.31	6.07	-2.66	46.29	25.8
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	98.78	21.66
Gross Profit, 5 Yr. CAGR %	-7.96	10.58	-	100.41	19.88
EBITDA, 5 Yr. CAGR %	17.15	15.85	20.4	17.32	28.19
EBITA, 5 Yr. CAGR %	17.67	16.18	20.4	17.33	27.85
EBIT, 5 Yr. CAGR %	17.69	16.19	20.41	17.25	27.3
Earnings From Cont. Operations, 5 Yr. CAGR %	20	19.78	20.11	18.24	29.15
Net Income, 5 Yr. CAGR %	20	19.78	20.11	18.24	29.15
Normalized Net Income, 5 Yr. CAGR %	19.49	18.45	21.03	17.42	26.41
Diluted EPS Before Extra, 5 Yr. CAGR %	8.33	6.36	6.23	4.82	13.1
Accounts Receivable, 5 Yr. CAGR %	-	-	-	49.5	22.02
Inventory, 5 Yr. CAGR %	-	-	-	63.93	28.34
Net Property, Plant and Equip., 5 Yr. CAGR %	64.42	56.98	52.36	35.76	0.43
Total Assets, 5 Yr. CAGR %	17.43	39.2	29.09	17.08	22.23
Tangible Book Value, 5 Yr. CAGR %	-2.55	9.48	-26.15	19.29	-14.55
Common Equity, 5 Yr. CAGR %	-2.41	21.58	-24.61	9.77	1.75
Cash From Operations, 5 Yr. CAGR %	16.85	19.88	20.2	15.76	22.23
Capital Expenditures, 5 Yr. CAGR %	12.56	11.66	26.91	0.3	-12.3
Levered Free Cash Flow, 5 Yr. CAGR %	11.98	15.96	17.48	20.1	16.05
Unlevered Free Cash Flow, 5 Yr. CAGR %	12.88	17.22	16.61	17.04	13.12